These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 22843168

  • 1. The untold story of Dabigatran etexilate: alveolar hemorrhage in an elderly patient with interstitial pulmonary fibrosis.
    Husari A, Beydoun A, Sheik Ammar A, Maakaron JE, Taher A.
    J Thromb Thrombolysis; 2013 Jan; 35(1):81-2. PubMed ID: 22843168
    [Abstract] [Full Text] [Related]

  • 2. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
    Eikelboom JW, Connolly SJ, Hart RG, Wallentin L, Reilly P, Oldgren J, Yang S, Yusuf S.
    J Am Coll Cardiol; 2013 Sep 03; 62(10):900-8. PubMed ID: 23770182
    [Abstract] [Full Text] [Related]

  • 3. Dabigatran-induced acute hepatitis.
    Rochwerg B, Xenodemetropoulos T, Crowther M, Spyropoulos A.
    Clin Appl Thromb Hemost; 2012 Sep 03; 18(5):549-50. PubMed ID: 22962308
    [No Abstract] [Full Text] [Related]

  • 4. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.
    Connolly SJ, Wallentin L, Ezekowitz MD, Eikelboom J, Oldgren J, Reilly PA, Brueckmann M, Pogue J, Alings M, Amerena JV, Avezum A, Baumgartner I, Budaj AJ, Chen JH, Dans AL, Darius H, Di Pasquale G, Ferreira J, Flaker GC, Flather MD, Franzosi MG, Golitsyn SP, Halon DA, Heidbuchel H, Hohnloser SH, Huber K, Jansky P, Kamensky G, Keltai M, Kim SS, Lau CP, Le Heuzey JY, Lewis BS, Liu L, Nanas J, Omar R, Pais P, Pedersen KE, Piegas LS, Raev D, Smith PJ, Talajic M, Tan RS, Tanomsup S, Toivonen L, Vinereanu D, Xavier D, Zhu J, Wang SQ, Duffy CO, Themeles E, Yusuf S.
    Circulation; 2013 Jul 16; 128(3):237-43. PubMed ID: 23770747
    [Abstract] [Full Text] [Related]

  • 5. Diffuse alveolar hemorrhage associated with dabigatran.
    Yokoi K, Isoda K, Kimura T, Adachi T.
    Intern Med; 2012 Jul 16; 51(18):2667-8. PubMed ID: 22989848
    [No Abstract] [Full Text] [Related]

  • 6. The importance of postapproval data for dabigatran.
    Redberg RF.
    JAMA Intern Med; 2015 Jan 16; 175(1):25. PubMed ID: 25365377
    [No Abstract] [Full Text] [Related]

  • 7. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
    Brunetti L, Chen C, White J.
    Consult Pharm; 2014 Mar 16; 29(3):169-78. PubMed ID: 24589766
    [Abstract] [Full Text] [Related]

  • 8. Intermittent haemodialysis and continuous veno-venous dialysis are effective in mitigating major bleeding due to dabigatran.
    Getta B, Muller N, Motum P, Hsu D, Zebeljan D, Rosenfeld D.
    Br J Haematol; 2015 May 16; 169(4):603-4. PubMed ID: 25425051
    [No Abstract] [Full Text] [Related]

  • 9. Gastrointestinal bleeding under dabigatran.
    Stöllberger C, Lindner K, Finsterer J.
    J Postgrad Med; 2014 May 16; 60(2):192-3. PubMed ID: 24823522
    [Abstract] [Full Text] [Related]

  • 10. A single centre experience of the efficacy and safety of dabigatran etexilate used for stroke prevention in atrial fibrillation.
    Yap LB, Rusani BI, Umadevan D, Muhammad Z, Hussin A, Kaur S, Omar R.
    J Thromb Thrombolysis; 2014 Jul 16; 38(1):39-44. PubMed ID: 24197653
    [Abstract] [Full Text] [Related]

  • 11. Intracranial hemorrhage during dabigatran treatment.
    Komori M, Yasaka M, Kokuba K, Matsuoka H, Fujimoto S, Yoshida M, Kameda K, Shono T, Nagata S, Ago T, Kitazono T, Okada Y.
    Circ J; 2014 Jul 16; 78(6):1335-41. PubMed ID: 24662438
    [Abstract] [Full Text] [Related]

  • 12. Management and outcomes of major bleeding during treatment with dabigatran or warfarin.
    Majeed A, Hwang HG, Connolly SJ, Eikelboom JW, Ezekowitz MD, Wallentin L, Brueckmann M, Fraessdorf M, Yusuf S, Schulman S.
    Circulation; 2013 Nov 19; 128(21):2325-32. PubMed ID: 24081972
    [Abstract] [Full Text] [Related]

  • 13. Is there really misuse and abuse of dabigatran?
    Eikelboom JW, Hankey GJ.
    Med J Aust; 2013 Apr 15; 198(7):358-9. PubMed ID: 23581946
    [No Abstract] [Full Text] [Related]

  • 14. Wandering pneumonia caused by dabigatran.
    Kono M, Hirota K, Yokoe A, Koumura C, Sakai T, Tojima H.
    Intern Med; 2014 Apr 15; 53(16):1825-7. PubMed ID: 25130119
    [Abstract] [Full Text] [Related]

  • 15. Uncontrollable haemorrhage following dabigatran prophylaxis.
    Sandhu PS, Wilson C, Dalton E, Bogdanov A.
    BMJ Case Rep; 2013 Jun 10; 2013():. PubMed ID: 23761516
    [Abstract] [Full Text] [Related]

  • 16. Reversing dabigatran in life-threatening bleeding occurring during cardiac ablation with factor eight inhibitor bypassing activity.
    Dager WE, Gosselin RC, Roberts AJ.
    Crit Care Med; 2013 May 10; 41(5):e42-6. PubMed ID: 23474679
    [Abstract] [Full Text] [Related]

  • 17. Risk of bleeding with dabigatran in atrial fibrillation.
    Hernandez I, Baik SH, Piñera A, Zhang Y.
    JAMA Intern Med; 2015 Jan 10; 175(1):18-24. PubMed ID: 25365537
    [Abstract] [Full Text] [Related]

  • 18. Agranulocytosis immediately after oral administration of cibenzoline and dabigatran in a patient with paroxysmal atrial fibrillation.
    Hayashi H, Kitoh K, Mitsunami K, Horie M.
    Intern Med; 2012 Jan 10; 51(15):1987-90. PubMed ID: 22864123
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of three methods of antithrombotic therapy in elderly patients with nonvalvular atrial fibrillation].
    Shevelev VI, Kanorskiĭ SG.
    Kardiologiia; 2012 Jan 10; 52(7):56-60. PubMed ID: 22839715
    [Abstract] [Full Text] [Related]

  • 20. Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.
    Bogatkevich GS, Ludwicka-Bradley A, Nietert PJ, Akter T, van Ryn J, Silver RM.
    Arthritis Rheum; 2011 May 10; 63(5):1416-25. PubMed ID: 21312187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.